CRB-701: a Second-Generation Nectin-4 Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors.

Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer

sutantatug envedotin (CRB-701) - Corbus Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42636059

Andrew Kolodziej; Can Yuan; Congcong Niu; Lu Lv; Mingyue Shen; Mo Dan; Xiwu Hui; Xixin Hu; Yang Zhang; Zhaopeng Sun

Aug 25, 2026